Skip to main content
Almirall S.A. logo

Almirall S.A. — Investor Relations & Filings

Ticker · ALM ISIN · ES0157097017 LEI · 95980020140005007996 MC Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2026-05-11 Share Issue/Capital Cha…
Country ES Spain
Listing MC ALM

About Almirall S.A.

http://www.almirall.com

Almirall S.A. is a global biopharmaceutical company specializing in medical dermatology. The company focuses on the research, development, manufacturing, and commercialization of proprietary medicines to address significant unmet needs in skin health. Leveraging scientific innovation, Almirall provides medical solutions designed to improve the well-being and quality of life for patients. Its operations encompass in-house research and development, strategic partnerships, and in-licensing to expand its portfolio of dermatological treatments.

Recent filings

Filing Released Lang Actions
Información sobre dividendos
Share Issue/Capital Change Classification · 91% confidence The document is an informational notice from Almirall, S.A. detailing an ‘ampliación de capital’ (capital increase) with free‐of‐charge shares to implement a flexible dividend. It includes background, legal basis, terms of the share issue (number of shares, rights, pricing), and execution calendar. This is a direct announcement of a new share issuance/capital change rather than a routine regulatory filing or report. Therefore, it fits the Share Issue/Capital Change category (Code: SHA).
2026-05-11 Spanish
Información sobre el calendario del dividendo
Share Issue/Capital Change Classification · 92% confidence The document is an official announcement by Almirall S.A. detailing the schedule for a free share capital increase as part of a flexible dividend system. It outlines key dates for the capital increase (share issue) and related trading and record dates. This is a corporate action announcement concerning a new share issue/capital change rather than a dividend amount notice or full report. Therefore, it falls under the Share Issue/Capital Change category (SHA).
2026-05-11 Spanish
Almirall remite presentación sobre los Resultados del primer trimestre de 2026
Investor Presentation Classification · 93% confidence The document is a slide deck titled “1T 2026 Resultados financieros y Business Update” prepared by Almirall, S.A. It includes an agenda with presenters (CEO, CSO, CFO), detailed financial highlights for Q1 2026 (sales, EBITDA, guidance), pipeline updates, product life-cycle management, partnership agreements, and extensive charts and tables. It is a presentation used for investor communication, containing strategy, market position, and operational updates rather than a formal regulatory filing or earnings release announcement. Therefore, it best fits the Investor Presentation category (IP).
2026-05-11 Spanish
Acuerdos adoptados por el Consejo de Administración
Board/Management Information Classification · 95% confidence The document is an announcement by Almirall’s Board of Directors of resolutions adopted following the Annual General Meeting, detailing re-elections and new appointments to the Audit, Sustainability, Nomination and Remuneration committees, as well as steps for the flexible dividend. This is a clear announcement of board and management changes, fitting the Board/Management Information category.
2026-05-11 Spanish
Información sobre dividendos
Share Issue/Capital Change Classification · 78% confidence The document is a detailed “documento informativo” prepared under EU prospectus rules describing the mechanics of a capital increase (a rights issue in lieu of a flexible dividend) following shareholder approval. It contains substantive details on the number of rights, formulas, timelines, and procedures for issuance of new shares. This is not merely a dividend amount notice nor a short announcement, but an actual capital change document. Therefore it best fits the “Share Issue/Capital Change” category (SHA).
2026-05-11 Spanish
Acuerdos adoptados por la Junta General de Accionistas 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 87% confidence The document is the official record of resolutions adopted at the Annual General Shareholders’ Meeting held on May 8, 2026, detailing the approval of annual accounts, non-financial information, dividend distribution, and amendments to the bylaws. It refers to an annex containing voting results. This matches a Declaration of Voting Results & Voting Rights Announcement, not the meeting presentation itself or the full annual report.
2026-05-11 Spanish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.